tiprankstipranks
Advertisement
Advertisement

CAMP Stock Latest News

Camp4 Therapeutics initiated with a Buy at Rodman & Renshaw
The FlyCamp4 Therapeutics initiated with a Buy at Rodman & Renshaw
13d ago
CAMP
Camp4 Therapeutics price target raised to $9 from $8 at Leerink
PremiumThe Fly
Camp4 Therapeutics price target raised to $9 from $8 at Leerink
25d ago
CAMP
CAMP4 Therapeutics Adds Veteran CFO MacLean to Board
PremiumCompany Announcements
CAMP4 Therapeutics Adds Veteran CFO MacLean to Board
1M ago
8K
CAMP
CAMP Earnings this Week: How Will it Perform?
PremiumPre-Earnings
CAMP Earnings this Week: How Will it Perform?
1M ago
CAMP
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
CAMP
SPRB
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
2M ago
CAMP
CAMP4 Highlights 2025 Results and SYNGAP1 Program Progress
Premium
Company Announcements
CAMP4 Highlights 2025 Results and SYNGAP1 Program Progress
2M ago
8K
CAMP
Camp4 Therapeutics participates in a conf call hosted by Cantor Fitzgerald
Premium
The Fly
Camp4 Therapeutics participates in a conf call hosted by Cantor Fitzgerald
2M ago
CAMP
CAMP4 Therapeutics updates corporate investor presentation materials
PremiumCompany Announcements
CAMP4 Therapeutics updates corporate investor presentation materials
4M ago
8K
CAMP
CAMP4 Therapeutics Restructures Leases and Expands Facilities
PremiumCompany Announcements
CAMP4 Therapeutics Restructures Leases and Expands Facilities
4M ago
8K
CAMP
CAMP4 Therapeutics: GSK Collaboration and Strengthened Funding Base De-Risk CMP-002 Development and Support Buy Rating
PremiumRatings
CAMP4 Therapeutics: GSK Collaboration and Strengthened Funding Base De-Risk CMP-002 Development and Support Buy Rating
4M ago
CAMP
CAMP4 Therapeutics Announces $28 Million Common Stock Offering
PremiumCompany Announcements
CAMP4 Therapeutics Announces $28 Million Common Stock Offering
4M ago
8K
CAMP
External Validation and Strengthened Balance Sheet Underpin Buy Rating on CAMP4 Therapeutics
PremiumRatingsExternal Validation and Strengthened Balance Sheet Underpin Buy Rating on CAMP4 Therapeutics
4M ago
CAMP
CAMP4, GSK form RNA therapeutics collaboration agreement
Premium
Company Announcements
CAMP4, GSK form RNA therapeutics collaboration agreement
4M ago
8K
CAMP
Camp4 Therapeutics prices 5M shares at $6.00 in underwritten public offering
Premium
The Fly
Camp4 Therapeutics prices 5M shares at $6.00 in underwritten public offering
4M ago
CAMP
Camp4 Therapeutics 5M share Secondary priced at $6.00
PremiumThe Fly
Camp4 Therapeutics 5M share Secondary priced at $6.00
4M ago
CAMP
Camp4 Therapeutics, GSK enter strategic collaboration
PremiumThe Fly
Camp4 Therapeutics, GSK enter strategic collaboration
4M ago
GSK
CAMP
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
CAMP
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
CAMP
IBIO
CAMP Earnings this Week: How Will it Perform?
PremiumPre-EarningsCAMP Earnings this Week: How Will it Perform?
5M ago
CAMP
Strategic Focus and Financial Strength Drive Buy Rating for CAMP4 Therapeutics
Premium
Ratings
Strategic Focus and Financial Strength Drive Buy Rating for CAMP4 Therapeutics
6M ago
CAMP
Camp4 Therapeutics initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Camp4 Therapeutics initiated with an Overweight at Cantor Fitzgerald
7M ago
CAMP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >